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The Impact of Small Molecule Binding on the Energy
Landscape of the Intrinsically Disordered Protein C-Myc
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Abstract
Intrinsically disordered proteins are attractive therapeutic targets owing to their prevalence in several diseases. Yet their lack
of well-defined structure renders ligand discovery a challenging task. An intriguing example is provided by the oncoprotein
c-Myc, a transcription factor that is over expressed in a broad range of cancers. Transcriptional activity of c-Myc is
dependent on heterodimerization with partner protein Max. This protein-protein interaction is disrupted by the small
molecule 10058-F4 (1), that binds to monomeric and disordered c-Myc. To rationalize the mechanism of inhibition,
structural ensembles for the segment of the c-Myc domain that binds to 1 were computed in the absence and presence of
the ligand using classical force fields and explicit solvent metadynamics molecular simulations. The accuracy of the
computed structural ensembles was assessed by comparison of predicted and measured NMR chemical shifts. The small
molecule 1 was found to perturb the composition of the apo equilibrium ensemble and to bind weakly to multiple distinct
c-Myc conformations. Comparison of the apo and holo equilibrium ensembles reveals that the c-Myc conformations binding
1 are already partially formed in the apo ensemble, suggesting that 1 binds to c-Myc through an extended conformational
selection mechanism. The present results have important implications for rational ligand design efforts targeting intrinsically
disordered proteins.
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Introduction
It is now apparent that many proteins do not adopt a unique
fold in native conditions, but rather exist as an ensemble of distinct
conformations in rapid exchange. [1,2] These intrinsically
disordered proteins (IDPs) are highly abundant in nature, it has
been suggested that up to half of proteins in mammals contain long
consecutive stretches (.30) of disordered residues. [3] IDPs often
participate in protein-protein interactions and form ordered
protein-complexes by coupled folding and binding. [4] This
molecular recognition mechanism is characterized by high-
specificity low-affinity complexes owing to the high entropic cost
of complex formation. [5] The structural flexibility of IDPs enables
interactions with several protein partners, explaining why IDPs
play essential roles in a broad range of cellular functions such as
cell-signaling and transcription. [1,2,5] Additionally IDPs have
been shown to be predominantly implicated in a wide range of
diseases. Iakoucheva et al. report that ca. 80% of cancer-
associated proteins are predicted to contain intrinsically disordered
regions, [6] whereas Uversky et al. have reported ca. 60% of
proteins associated with cardiovascular and neurodegenerative
disorders can also be classified as IDPs. [7] Given the important
role of IDPs in human health, the development of small molecule
chemical probes to modulate IDP function is desirable. [8,9] The
task is challenging, historically IDPs have largely been considered
‘‘undruggable’’, so there is little prior data to guide ligand-based
design methods. The considerable structural flexibility of IDPs also
limits the applicability of established structure-based methods such
as NMR or crystallography to probe in details protein-ligand
interactions. [10] Yet a few success stories suggest that small
molecule inhibition of IDPs may be feasible.
The oncoprotein c-Myc provides a striking example. Tempo-
rary inhibition of c-Myc has been shown to selectively kill mouse
lung cancer cells, and c-Myc is therefore a potential cancer drug
target. [11] c-Myc belongs to the Myc family of transcription
factors and Myc-dependent transactivation requires heterodimer-
ization of its basic-Helix-Loop-Helix-Leucine zipper (bHLHZip)
domain with the bHLHZip domain of the partner protein Max.
[12] The c-Myc/Max heterodimer interface is a parallel, left-
handed, four-helix bundle where each monomer forms two a-
helices separated by a small loop. The bHLHZip domains of
monomeric c-Myc and Max are intrinsically disordered and the c-
Myc/Max complex is thus an example of coupled folding and
binding. Several inhibitors of c-Myc/Max have been identified in
the past decade. [13] Notably Yin et al. used a high-throughput
screen to identify structurally diverse small molecule inhibitors of
the c-Myc/Max interaction. [14] Extensive biophysical studies of
small molecule binding to c-Myc have been performed using
NMR, circular dichroism and fluorescence assays. [15,16,17]
These studies have led to the conclusion that many of the small
molecules inhibitors disrupt the c-Myc/Max interaction by
binding to monomeric c-Myc and stabilizing conformations
incompatible with Max heterodimerization, as illustrated in
Figure 1.
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Remarkably, multiple distinct small molecule binding sites are
present in the c-Myc bHLHZip domain. Hamoudeh et al. have
shown that small molecule ligands that target distinct sites can
bind simultaneously to the c-Myc bHLHZip domain. In addition,
truncated segments of 10–40 amino acids bind different small
molecule ligands with similar affinity to the full length domain.
These observations suggest that the protein/ligand interactions are
local and largely dictated by the protein primary sequence. [17]
To illustrate, the small molecule 10058-F4 (1) binds c-Myc353–437
with a Kd of 5 mM and c-Myc402–412 with a Kd of 13 mM in a
fluorescence polarization assay. [16] Additionally, similar chemical
shift perturbations are observed upon binding of 1 to c-Myc353–437
and c-Myc402–412. Therefore c-Myc402–412 is a good model of the
interactions of 1 with full length c-Myc. Although the measured
Kds indicate 1 does not bind strongly c-Myc, they are similar to
the measured Kds for formation of the c-Myc/Max complex (ca.
1 mM), [15] thus 1 can disrupt effectively the c-Myc/Max
interaction. Indeed, extensive cellular studies of c-Myc function
have been performed with 1, [18,19] but rapid clearance has
hindered progress to animal models and clinical studies. [20] The
development of improved c-Myc/Max inhibitors to evaluate new
clinical anti-cancer therapies would benefit greatly from detailed
structural models of c-Myc/small molecule interactions. [21] More
generally IDPs have just started to be considered druggable and it
is important to establish the mechanisms of molecular recognition
between small molecules and IDPs to guide rational drug design
efforts. [8,9].
Molecular dynamics (MD) simulations present an attractive
option to achieve this goal given the difficulty in obtaining high-
accuracy IDP structures using biophysical methods. [10,22]
Simulation studies of IDPs do raise profound technical challenges.
The reliability of standard biomolecular force fields for IDPs is not
well understood as they have been historically validated against
other protein classes. Further, accurate resolution of IDP
ensembles requires extensive conformational sampling which
remains difficult to achieve and currently requires either massive
computational power, coarse-graining, implicit solvent models, or
enhanced sampling methods. [23,24] Nevertheless, molecular
simulation studies have already shed new insights into IDP
structure and mechanisms of interactions with other proteins.
[25,26,27,28,29,30,31].
In the present manuscript, the bias-exchange variant of the
metadynamics method (BEMD) has been used to sample
extensively the energy landscape of c-Myc402–412 (sequence
YILSVQAEEQK) and the c-Myc402–412/1 complex using
explicit solvent models and classical force-fields. [32,33] Detailed
comparison of the computed apo (c-Myc402–412 alone) and holo
(c-Myc402–412 in the presence of 1) structural ensembles reveals
how ligand binding modulates the equilibrium ensemble of c-
Myc402–412, provides new insights into the mechanisms of
molecular recognition between a small molecule and an IDP,
and has important implications for structure-based strategies to
design improved c-Myc/Max inhibitors.
Results
Enhanced Sampling Improves the Accuracy of the
Computed c-Myc402–412 Structural Ensemble
Exhaustive enumeration of structural ensembles for IDPs is a
challenging task. In this study structural ensembles for c-Myc402–
412 and the c-Myc402–412/1 complex were obtained using the bias-
exchange metadynamics technique. [33] The approach entails
running a set of molecular dynamics simulations. The sampling of
molecular conformations in each simulation is biased by a history-
dependent potential constructed as a sum of Gaussians centered
on a collective variable (CV). After an equilibration period, the
Gaussian biases compensate free energy barriers and rapid
diffusive behavior is achieved along the CV. [34] In addition,
exchanges between the biasing potentials used in the different CVs
are periodically attempted according to a replica exchange
scheme. Finally, a neutral replica that is not biased by any CV
is also simulated. The neutral replica has been shown in other
studies to produce an ensemble similar to the equilibrium
ensemble of the system. [33,35,36,37] BEMD has been shown to
allow extensive sampling of the folding free energy landscape of
small proteins and protein/ligand complexes on timescales of a
few dozen ns (see Methods for details on the protocols used).
[32,38] Convergence of the simulations was first assessed by
constructing several one dimensional free energy profiles along the
CVs used to enhance conformational sampling. These were
obtained from the negative of the accumulated Gaussian biases
along each CV, which in the limit of a sufficiently long simulation,
reproduce the free energy of the system up to an additive constant.
To assess reproducibility of the free energy profiles two apo and
holo simulations were performed, each initiated from uncorrelated
sets of configurations. The results are shown in Figure 2 and 3. In
general the free energy profiles within 10 kJ/mol of the global
minimum are well reproduced (within ca. 1 kBT or less) for most
Figure 1. Small molecule inhibition of the c-Myc/Max interaction. The small molecule 10058-F4 (1, purple star) disrupts heterodimerization
of the bHLHZip domains in c-Myc (blue) and Max (red) by stabilizing conformations in monomeric c-Myc incompatible with c-Myc/Max dimerizaton.
doi:10.1371/journal.pone.0041070.g001
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CVs between the two independent simulations. The largest
discrepancy is observed for CV2 in the apo simulations in the
range of CV values of 40–50. In the holo simulations, more
variability is observed in the regions of high free energy for CV3
and CV4 (Fig. 3C and Fig. 3D). Conformations in these regions
contribute little weight to the equilibrium ensemble, and the
overall equilibrium properties obtained by reweighting statistics
from the biased simulations (see Methods) are fairly consistent for
the two independent simulations (e.g. Table 1 and Figure 4).
Visualization of the apo neutral replica ensemble reveals that a
broad range of compact, extended, structured and unstructured
conformations have been sampled in both simulations (Figure S1
panel A). The BEMD neutral replica ensembles were compared to
two 100 ns unbiased MD simulation performed using the same
potential energy function and system setup. The first MD
simulation was initiated from an extended conformation which
collapses into a short a-helical conformation around Leu404-Ala408
after a few ns. This a-helix occasionally briefly unwinds, but
remains otherwise stable throughout the simulation, eventually
extending to include Ile403 and Tyr402 after about 90 ns (Figure S1
panel C). The conformations sampled in the second MD
simulation are very different and mostly unstructured (Figure S1
panel D). Thus the unbiased MD simulations provide an
inconsistent picture of the c-Myc402–412 structural ensemble in
comparison to the BEMD simulations. It is likely that orders of
magnitude increase in the duration of the MD simulation would
be necessary to achieve a sampling of the energy landscape
comparable to the BEMD simulation for this system.
To assess the accuracy of the computed ensembles, snapshots
collected during the MD and BEMD simulations of c-Myc402–412
were used to back-compute NMR chemical shifts using the
software Camshift. [39] Figure 4 compares with available
experimental data the computed 1H and 13C secondary chemical
shifts for Ha protons, backbone amide protons, Ca and Cb
carbons. [15] The secondary chemical shifts computed from the
two BEMD ensembles are fairly consistent and there is little
difference between the chemical shifts obtained by averaging over
snapshots from the neutral replicas or by reweighting snapshots
from the biased simulations (Figure 4). By contrast, greater
variability and inconsistency is observed between the chemical
shifts computed from the two unbiased MD simulations (Figure
S2). The mean-unsigned errors for the Ha, H, Ca and Cb chemical
shifts computed from the two reweighted BEMD simulations are:
0.09/0.08, 0.43/0.44, 0.32/0.28 and 0.35/0.32 ppm respectively.
These figures are very similar to the mean-unsigned errors
computed for the neutral replica ensembles: 0.09/0.08, 0.45/0.46,
0.32/0.29 and 0.34/0.35 ppm respectively. By comparison the
mean-unsigned errors computed from the two MD simulations
are: 0.15/0.13, 1.25/0.80, 0.50/0.42, 1.01/0.86 ppm respectively.
Thus in addition to predicting equilibrium properties that are
much more consistent between independent runs, the overall
errors in predicted secondary chemical shifts have been roughly
halved using the BEMD protocol.
The overall secondary structure content of the computed
ensembles estimated using the software DSSP, [40] STRIDE, [41]
and PROSS [42] for the BEMD and MD simulations is reported
in Table 1. These figures can be compared to the secondary
structure content estimated from experimentally measured chem-
ical shifts using the software d2D. [43] The first MD ensemble
largely overestimates the helical content of c-Myc402–412, fails to
detect any sheet content and underestimates the polyproline II
content. The second MD ensemble has a negligible amount of
helical structures or sheet content, but reproduces better the
polyproline II content measured experimentally. By contrast the
structural ensembles computed by BEMD simulations are fairly
consistent to within a few percent. The helical content is
overestimated and the sheet content slightly underestimated,
which may reflect a systematic bias from the force field used in the
simulations. The computed polyproline II content is otherwise in
good agreement with the measured polyproline II content. Given
that both simulations have been performed on the same system
with the same force field, the greater discrepancies in computed
observables for the MD simulation arise from greater sampling
errors. Although it is likely that optimized force fields could
decrease further discrepancies with experiment, the computed
BEMD ensemble is overall in reasonable agreement with the
available experimental data for this system.
The equilibrium properties of c-Myc402–412 predicted by
reweighting the biased simulations or by simple averaging over
snapshots sampled by the neutral replica are remarkably similar
(Table 1, Fig. 4). This suggests, in agreement with other bias-
exchange metadynamics studies, that the neutral replica is a good
approximation of the canonical ensemble. To assert further this
claim, one-dimensional free energy profiles along all collective
variables used in the biased simulations were constructed from the
statistics collected in one of the neutral replica. Comparison of the
free energy profiles between the neutral replica and the biased
simulations (Figure S3) indicates that the global minimum in free
energy is well reproduced, but that regions of high free energy are
systematically overrepresented in the neutral replica. This
observation explains why the equilibrium properties predicted by
reweighting the biased simulations or by averaging over snapshots
sampled from the neutral replica agree well, since conformations
of low free energy contribute with a greater weight to the
equilibrium properties of the system. Nevertheless this analysis
suggests that the accuracy of the neutral replica ensemble
decreases rapidly for conformations of higher free energy.
Consequently, analyses in the rest of the manuscript were
performed on ensembles constructed by reweighting snapshots
from the biased simulations (see Methods).
The c-Myc402–412 Apo Ensemble Contains Collapsed,
Extended and Helical Conformations
The equilibrium ensemble is heterogeneous and includes several
extended and collapsed conformations, consistent with c-Myc402–412
Table 1. Percentage of secondary structure content of apo c-
Myc402–412.
1
Helix Sheet Polyproline II
BEMD run 1 13.9 10.0 0.7 0.9 12.6
BEMD run 2 10.9 9.4 0.6 0.2 12.1
BEMD run1
neutral
14.2 11.9 0.7 1.0 11.6
BEMD run2
neutral
10.5 9.2 0.5 0.2 11.7
MD run 1 34.3 41.5 0 0 5.5
MD run2 0.1 0.1 0.5 0.5 13.5
Exp2 4 3 13
1helix and sheet content computed according to the DSSP and STRIDE methods
respectively. A helix was defined as G + H + I and a sheet as B + E using the 7
letter DSSP code. The polyproline II content was estimated using the software
PROSS.
2Secondary structure content estimated from measured chemical shifts, using
the webserver d2d.
doi:10.1371/journal.pone.0041070.t001
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being intrinsically disordered. Clustering indicates there are dozens
of structurally diverse clusters of conformations. [44] Figure 5 shows
representative conformations from the ninth largest clusters
calculated for the apo ensemble. Although the ensemble properties
of the peptide are well reproduced, not all clusters are equally well
populated in the two independent BEMD simulations, as evidenced
by the standard error estimates of the cluster populations. Longer
simulations would be required to obtain more precise population
estimates. The largest cluster (Figure 5A) is a random coil structure
stabilized by hydrophobic contacts between Tyr402, Ile403 and
Val406 and electrostatic interactions between Lys412 and Glu409.
Other partially collapsed conformations are apparent (e.g. Figure 5D
and 5E), but extended conformations are also observed (e.g
Figure 5F and 5I). Additionally, several clusters include conforma-
tions containing short a or 310 helices (Figure 5B, 5G), that account
for the overall computed helical content of c-Myc402–412.
c-Myc402–412 Remains Disordered upon Binding the Small
Molecule 10058-F4
To assess the impact of the binding of 1 on the conformations of
c-Myc402–412, the average number of contacts between protons
(d,3.0 A˚) in 1 and different protein residues was computed for the
apo and holo BEMD simulations. Figure 6 shows the difference in
contact probabilities between the holo and apo simulations, red
indicates increased contact probabilities, blue indicates decreased
contact probabilities, whereas white indicates unchanged contact
probabilities. Figure 6A shows that 1 contacts primarily the N-
terminal region of c-Myc402–412, with a strong preference for
contacts with Tyr402. Lys412 is the only side-chain in the C-
terminal region of c-Myc402–412 that forms significant contacts
with 1. Given that 1 contains a moderately polar heterocycle and a
hydrophobic ethylphenyl group, it is not surprising that intermo-
lecular contacts occur preferentially with the N-terminal region as
it is enriched in hydrophobic amino acids. Figure 6B depicts the
difference in average number of contacts between protein residues
in the apo and holo simulations. This analysis reveals whether
ligand binding changes contact probabilities between residues in c-
Myc402–412. Overall decreased contacts of Tyr402 with nearby
amino-acids are observed because 1 lies frequently between these
side-chains. Increased contacts between Lys412 and the N-terminal
amino acids correlate with decreased contats with amino acids in
the C-terminal region. This occurs because c-Myc402–412 adopts
more frequently conformations that wrap around 1. Comparison
of computed and measured chemical shifts for the c-Myc402–412/1
complex is not possible owing to the lack of parameters in
Camshift to describe the ligand. However the simulations suggest
formation of a hydrophobic cluster between 1 and the side chains
of Tyr402, Ile403, Leu404, Val406, which is in qualitative agreement
Figure 2. Free energy profiles for the c-Myc402–412 apo simulations projected along several collective variables. Black: Simulation
apoA, Red: Simulation apoB. A) CV1, B) CV2, C) CV3, D) CV4 E) CV5 F) CV6 G) CV7. See the Methods section in the main text for a definition of each CV.
doi:10.1371/journal.pone.0041070.g002
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with the interpretation of the limited NOEs measured by Follis
et al. [16] The holo ensemble remains heterogeneous, thus
binding of 1 does not structure considerably c-Myc402–412. The
overall helical content, 1361% or 1161% (DSSP and STRIDE
respectively), is relatively unchanged from the apo ensemble. The
negligible sheet content, and polyproline II content, 1261%
(PROSS) are broadly similar to the quantities computed for the
apo ensemble.
The Small Molecule 10058-F4 Binds to Multiple Distinct c-
Myc402–412 Conformations
Although there are no dramatic changes in secondary structure
content upon ligand binding, detailed analysis reveals that the
nature and the population of the c-Myc402–412 equilibrium
conformations is substantially affected by 1. The ligand retains
considerable mobility and can adopt a multitude of different
binding modes against structurally distinct c-Myc402–412 confor-
mations. Consequently clustering analysis of the holo ensemble
produces a large number of negligibly populated clusters.
Nevertheless, it is possible to identify more frequently observed
binding modes. Figure 7 depicts nine conformations representative
of the most populated clusters from the holo ensemble. The first
cluster (Figure 7A) features stacking interactions between the
phenyl rings of 1 and Tyr402, as well as hydrophobic contacts
between the ethylphenyl group of 1 and Leu404. Ile403 forms a
small hydrophobic cluster with Leu404 and Tyr402. Additional
stabilizing hydrogen-bonding interactions between Gln411 and the
peptide backbone are present. In Figure 7B the ethylphenyl group
of 1 is sandwiched between the side-chains of Tyr402 and Lys412,
whereas the thiazolidinone ring forms hydrogen bonding interac-
tions with the backbone of Leu404 and Gln407. In some cases
(Figure 7D, 7I) the ligand stabilizes a-helical conformations
whereas in several other clusters, 1 forms relatively limited
contacts with the more hydrophobic N-terminus (Figure 7E, 7F,
7G, 7H). Comparison of the computed holo c-Myc402–412
conformations with the conformation of c-Myc402–412 observed
in the crystallographic structure of the c-Myc/Max dimer
systematically indicates steric clashes with Max, [12] thus binding
of 1 to c-Myc is not compatible with c-Myc/Max dimerization.
The broad range of c-Myc conformations binding 1 may
explain the relatively forgiving structure-activity relationships
observed for analogs of 1, [21,45] i.e. few small ligand
modifications would prevent binding to all observed conforma-
tions. The most populated conformations do not closely resemble
the structure of the c-Myc402–412/1 complex derived using
chemical-shift constraints and docking. [16] As it has been pointed
Figure 3. Free energy profiles for the c-Myc402–412/1 holo simulations projected along several collective variables. Black: Simulation
holoA, Red: Simulation holoB. A) CV1, B) CV2, C) CV3, D) CV4, E) CV5, F) CV6, G) CV7, H) CV8. See the Methods section in the main text for a definition
of each CV.
doi:10.1371/journal.pone.0041070.g003
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out by Follis et al., a single average structure obtained from
minimization of NMR derived restraints may not be representa-
tive of the multiple distinct conformations adopted by a disordered
protein. [16] This highlights the usefulness of molecular dynamics
simulation protocols to generate structural ensembles for IDPs and
guide the interpretation of NMR measurements.
The c-Myc402–412 Conformations Binding 10058-F4 are
Partially Formed in the Apo Ensemble
To investigate the mechanisms of molecular recognition, the
frequently observed apo and holo c-Myc402–412 conformations
were compared to the computed apo and holo ensembles. Broad
fluctuations in backbone conformations are observed within the
apo and holo ensembles, Figure 8A–D reports histograms of
backbone root mean square deviation (RMSD) of the apo and
holo structural ensembles to selected holo and apo conformations
depicted in Figure 5 and Figure 7. There is some arbitrariness in
the definition of a criterion to consider whether two conformations
are structurally similar, but overlay of several low RMSD
structures suggests that a backbone RMSD around 2.5 A˚ or less
identifies broadly similar backbone conformations for this system.
According to this criterion, in all cases the c-Myc402–412 apo
ensemble contain conformations that are structurally similar to
those seen more frequently in the holo ensemble (Figure 8A–8C,
insets), albeit with a lower probability. Likewise, the holo ensemble
also contains conformations that have a RMSD,2.5 A˚ to the apo
conformation shown in Figure 5A (Figure 8D). To illustrate,
Figure 8 also depicts an overlay of the conformation sampled from
the apo (Figure 8A–8C) or holo (Figure 8D) ensemble that has the
lowest RMSD to the apo/holo conformations depicted in
Figure 7A–7C and Figure 5A. These results suggest that there is
significant structural overlap between the apo and holo ensembles.
However additional side-chain adjustments are typically necessary
to dock 1 into the apo structures to reproduce the holo
conformations depicted in Figure 7 because a few side-chains
would otherwise clash with the ligand.
Discussion
In comparison with standard molecular dynamics, the present
bias-exchange metadynamics simulations have been shown to
dramatically enhance conformational sampling in explicit solvent
of a segment of the intrinsically disordered protein c-Myc. These
results add to the growing literature evidence for the usefulness of
metadynamics to study biomolecular interactions. [32,38] Because
standard biomolecular force fields have not been tested extensively
on intrinsically disordered proteins, it is important to validate as
much as possible computed trajectories against experimental data.
NMR is an established methodology to perform experimental
studies of IDPs structure, and the back-computation of chemical
shifts from molecular dynamics trajectories provides an excellent
opportunity to connect simulations with experiments for disor-
dered proteins. [46] The larger errors in predicted chemical shifts
for the MD simulation versus the BEMD simulations reported in
this manuscript highlight the importance of achieving a broad
sampling of energy landscapes, at least the regions of low free
energy, to reliably compare simulations with experiments. The
simulated ensembles will otherwise not be well reproducible, and it
will be difficult to diagnose systematic force field errors and devise
more accurate potential energy functions [47].
The current results indicate that there is large conformational
heterogeneity in both the apo and holo equilibrium ensembles of
c-Myc402–412. To obtain a complete picture of the energy
landscape it would be desirable to obtain as well information
Figure 4. Comparison of computed and observed secondary
chemical shifts for apo c-Myc402–412. A)
1Ha chemical shifts. B)
13Ca
chemical shifts. C) 1H backbone amide chemical shifts. D) 13Cb chemical
shifts. Black: experimental data. Solid red and blue: predicted by
reweighting the biased BEMD simulations apoA and apoB respectively.
Dotted red and blue: predicted from the neutral replicas of the BEMD
simulations apoA and apoB respectively. Not all experimental 13Cb
chemical shifts were reported. Camshift does not report chemical shifts
for terminal residues.
doi:10.1371/journal.pone.0041070.g004
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about kinetic properties. Owing to the use of a replica-exchange
methodology and a time-dependent biasing potential, this
information is not readily accessible from the present BEMD
simulations. It is possible to project the BEMD trajectories on a
space defined by the collective variables to build a kinetic model,
[35] however we find that this analysis is of limited utility here
because the structural ensemble of c-Myc402–412 is too diverse to
resolve well several kinetic basins in a low dimensional CV space.
An interesting alternative would be to conduct extended unbiased
MD simulations to reversibly simulate binding/unbinding in this
system and analyze the computed trajectories using Markov State
models. [48,49] Such study could also allow in principle a direct
Figure 5. Representative conformations from the computed equilibrium ensemble for apo c-Myc402–412. The conformations depicted
are those closest to the center of the most populated clusters. The fractional cluster populations are: 0.10160.018 (A), 0.07560.034 (B), 0.06060.040
(C), 0.05960.027 (D), 0.05560.016 (E), 0.04360.004 (F), 0.03060.017 (G), 0.02160.009 (H), 0.02160.003 (I). Figure prepared with the software VMD
[78].
doi:10.1371/journal.pone.0041070.g005
Figure 6. Average number of contacts between 1 and c-Myc402–412. A) Average number of
1H contacts between different c-Myc402–412
residues and 1. Color coded from white (no contacts) to red (high number of contacts). The extreme values of this color scale range from 0.02 to 1.08.
B) Difference in the average number of 1H contacts between different c-Myc402–412 residues in the holo and apo ensembles. Red/blue indicates an
increased/decreased average number of contacts upon binding of 1. The extreme values of this color scale range from 21.22 to +0.67.
doi:10.1371/journal.pone.0041070.g006
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estimation of dissociation constants and kinetics of binding and
conformational transitions, [50] although it may be difficult to
unambiguously define bound/unbound states for an IDP.
An intriguing result from this study is the observation that no
clearly dominant binding mode emerges for the c-Myc402–412/1
complex. Rather, binding seems to result from a multitude of weak
interactions to distinct conformations. This contrasts with the
frequently observed disorder-to-order transitions in complexes
involving one or two IDPs. [5,51] Coupled folding and binding
typically arises from a fine balance between a large conformational
entropy loss and the formation of several intermolecular contacts
across an often large interface. [5] Arguably, a drug-like molecule
may be too small to form extended contacts that could overcome
the large conformational entropy loss required to structure a
disordered protein. Thus it seems more likely that the current
small molecule inhibitors of c-Myc/Max stabilize a broad range of
inactive c-Myc conformations, rather than conformationally
trapping c-Myc in an inactive state. [52] The fact that several
structurally diverse small molecules inhibitors of c-Myc/Max were
identified with a reasonable success rate through screening
relatively modest libraries supports the hypothesis that the
conformational flexibility of IDPs facilitates interactions with
small molecules through a large number of weak interactions. [8]
Further evidence in support of this molecular recognition
mechanism is provided by examples of IDPs that remain partially
disordered when in complex with other proteins, for instance the
CFTR/NBD1 complex, [53] or the cytoplasmic domain of the T-
cell receptor e chain/SIV nef protein complex. [54] The lock and
key model cannot explain binding in the system studied here, but
neither would pure conformational selection or induced fit
mechanisms. The backbone conformations of c-Myc402–412 that
more frequently bind 1 are populated with a lower probability in
the apo ensemble, but further minor conformational adjustments,
mainly repositioning of side-chains, are necessary before 1 can be
docked without steric clashes. These observations are more in line
with the extended conformational selection model to describe
ligand binding in this system. [55] A recent simulation study using
Go˜ models from Ganguly et al. also favors this mechanism for the
binding of the NCBD domain of CBP with the p160 steroid
receptor coactivator ACTR. [56] Cino et al. have also reached
similar conclusions from a molecular dynamics study of the
interactions of the IDP Prothymosin alpha with the Neh2 domain
of Nuclear factor erythroid 2-related factor 2 and Kelch-like ECH-
associated protein 1. [57] To obtain further evidence, extensive
reversible atomistic simulations of the binding/unbinding of 1 to
c-Myc402–412 are desirable to establish the nature of the transition
state conformations.
The broad range of observed protein/ligand interactions in this
system raises profound questions regarding the possibility of
designing specific small molecule ligands for IDPs. The contact
matrix in Figure 6A, as well as the representative snapshots in
Figure 7 suggest that 1 interact preferentially with Tyr402. The
primary sequence of the c-Myc bHLHZip domain contains a
single Tyrosine, furthermore, the c-Myc segment 401–406
contains a cluster a hydrophobic amino acids that defines the
most hydrophobic region of the c-Myc bHLHZip sequence in a
hydrophobicity plot (Figure S4). Thus a simple explanation for the
location of the c-Myc binding site of 1, is that the ligand binds to
this segment because it contains several hydrophobic and aromatic
residues. Interestingly, the bHLHZip domain of the protein Max
lacks such hydrophobic clusters and appears overall less hydro-
phobic on a hydrophobicity plot (Figure S4). This may explain
why the ligand 1 does not disrupt the Max/Max homodimer.
Nevertheless, experimental evidence suggests that many of the
small molecules inhibitors of c-Myc/Max identified from in vitro
and cellular assays also disrupt other related protein-protein
Figure 7. Representative conformations from the computed equilibrium ensemble for the c-Myc402–412/1 complex. The conformations
depicted are those closest to the cluster center. The fractional cluster populations are: 0.02160.008 (A), 0.01960.002 (B), 0.01860.005 (C),
0.01560.010 (D), 0.01460.003 (E), 0.01160.008 (F), 0.01160.005 (G), 0.01160.001 (H), 0.01060.003 (I). Figure prepared with the software VMD [78].
doi:10.1371/journal.pone.0041070.g007
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Figure 8. Comparison of selected holo and apo conformations to the apo and holo ensembles. A) Probability distribution of backbone
RMSD of conformations from the apo (black curve) and holo (red curve) ensembles to: A) holo cluster center 7A, B) holo cluster center 7B, C) holo
cluster center 7C, D) apo cluster center 5A. The inset shows the low-RMSD regions. Each panel also shows an overlay of the lowest RMSD apo or holo
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interactions. [8] In a series of yeast two hybrid assays on 32 HLH,
HLHZip or bZip pairs, the small molecule 1 was found to inhibit
strongly c-Myc/Max, but also to inhibit moderately Myod/E2–2,
Mad1/Max, Mxi1/Max and Mad3/Max. [14] Given that the
present simulations suggest that ligand binding to c-Myc is
primarily driven by weak non specific interactions with hydro-
phobic patches, it is interesting to establish why 1 has been
identified as a c-Myc/Max inhibitor in previous high-throughput
screens. A noteworthy feature of 1, as well as several other
reported c-Myc ligands, is the presence of a benzylidene rhodanine
scaffold. Such class of small molecules frequently produces low-
micromolar hits in a broad range of assays and against diverse
biomolecular targets. [58] Mengden et al. have analysed in details
the binding promiscuity of rhodanines and concluded that this
behavior is not related to aggregation or reactivity towards
biological nucleophiles, but rather that this scaffold has a
pronounced propensity to form intermolecular interactions with
proteins. [59] Indeed Wang et al. recently reported the discovery
of a benzylidene-rhodanine ligand highly similar to 1 (o-nitro
group instead of p-ethyl group on the benzylidene group) and that
binds to the bZIP domain of the transcription factor DFosB. [60]
Although other scaffolds have been reported to disrupt the c-Myc/
Max interaction by binding to monomeric c-Myc, these observa-
tions suggest that the binding specificity of novel c-Myc ligands
should be carefully assessed against a broad range of targets. There
are documented cases of initial non specific hits obtained from
small molecule library screen that were subsequently optimized to
show higher specificity for c-Myc/Max. [61,62] Although clearly a
challenging endeavor, one could seek to exploit the present
computational approach to modify 1 in order to enhance binding
affinity towards c-Myc conformations that offer several contacts to
the ligand whilst minimizing binding affinity to conformations
likely to offer little ligand specificity. Alternatively, larger synthetic
molecules that disrupt c-Myc/Max by folding c-Myc upon binding
may achieve higher binding specificity.
Materials and Methods
Metadynamics Simulations
The AMBER99SB* forcefield was selected for c-Myc402–412 as it
has been calibrated to reproduce the secondary structure
preferences of peptides, [63] the GAFF forcefield for 1, [64] and
the TIP3P model was used for water. [65] The GAFF parameters
for the ligand were obtained by using the software acpype, [66] in
combination with the antechamber utility from the AMBER11
software package. [67] Atomic partial charges were assigned using
the AM1-BCC method. [68,69] Molecular models of c-Myc402–412
and the c-Myc402–412/1 complex were built in an extended
conformation using the software Maestro. [70] The peptide
termini were acetylated and amidated to be consistent with
experimental data. The models were then solvated in a triclinic
box of 2843 and 3211 water molecules respectively and charge
neutrality was enforced through introduction of one sodium ion.
The simulations were performed at 300 K and 1 atm with the
software package GROMACS 4.5.5, [71] compiled with the
metadynamics plugin PLUMED 1.3. [72] Apo and holo
simulations were initially equilibrated in NPT conditions, using a
stochastic Berendsen thermostat and Parinello-Rahman barostat
with relaxation times of 0.1 and 2 ps respectively. [73,74] A time
step of 2 fs was used. Particle-mesh Ewald was used to treat long-
range electrostatic interactions with a short-range cutoff of 0.9 nm.
A cutoff of 0.9 nm was used for the Lennard-Jones interactions. A
long-range correction term was used for the energy and pressure.
[75] After NPT equilibration, BEMD simulations were performed
in NVT conditions as the PLUMED software does not compute
the contribution of the metadynamics forces to the virial. Short
preliminary runs were performed to optimize the selection of CVs
and Gaussian parameters. The CVs were chosen on the basis of
previously published BEMD studies to remove possible energetic
barriers between degrees of freedom describing backbone and
side-chain conformational changes. The parameters of the CVs
(Gaussian height and width), which control the rate of conver-
gence and accuracy of the free energy profiles were adjusted in
preliminary runs in implicit solvent so as to obtain reasonably
converged free energy profiles on a timescale of several dozen
nanoseconds. The apo and holo simulations were performed with
8 and 9 replicas respectively. In the production runs, each replica
was simulated for 120 ns. Each simulation was repeated twice,
using different starting coordinates for each replica. These starting
coordinates were obtained from preliminary runs and it was
checked that they were structurally diverse and uncorrelated. Thus
a total of 4 BEMD simulations were performed: two apo
simulations (apoA and apoB) and two holo simulations (holoA
and holoB).
Gaussian potentials of height 0.2 kJ.mol-1 were added every
2.0 ps. Collective variables and snapshots were saved every 2.0 ps
and exchanges between replicas were attempted every 20.0 ps. All
bond lengths were constrained to their equilibrium length with the
LINCS algorithm. [76] The CVs used in the production runs
were:
N Apo simulations: CV1: coordination number Ca atoms.
width 0.7; CV2: coordination number Cc atoms, width 0.5;
CV3, similarity of backbone dihedral psi angle to a-helical
region, width 0.25; CV4, correlation of successive backbone
dihedral angles; CV5: number of backbone - backbone
hydrogen bonds, width 0.25; CV6: number of sidechain -
sidechain hydrogen bonds, width 0.25; CV7: number of
sidechain - backbone hydrogen bonds, width 0.25;
N Holo simulations: CV1: coordination number Ca atoms.
width 0.7; CV2: coordination number Cc atoms, width 0.5;
CV3, similarity of backbone dihedral psi angle to a-helical
region, width 0.25; CV4, correlation of successive backbone
dihedral angles; CV5: number of backbone - backbone
hydrogen bonds, width 0.25; CV6: number of sidechain -
sidechain hydrogen bonds, width 0.25; CV7: number of
sidechain - backbone hydrogen bonds, width 0.25; CV8:
minimum distance ligand C1 atom to peptide Ca atoms. C1 is
the aromatic carbon atom bonded to the methylene
group of 1.
Accumulation of the biases gradually enables exploration of a
larger range of values along each CV. This trend is more
pronounced for CVs defined by counting interatomic contacts and
eventually leads to the sampling of high energy configurations that
cause hysteresis in the convergence of the free energy profiles for
the biased replicas. However these high-energy configurations are
almost never transferred to other replicas during replica exchange
tests. To maintain a reasonable exchange rate between replicas
and to focus conformational sampling in the regions of low free
structure to cluster centers from panels A–D. For clarity only the peptide backbone (tube representation, apo conformations in blue, holo
conformations in orange) and ligand atoms (CPK) are shown. Figure prepared using VMD [78].
doi:10.1371/journal.pone.0041070.g008
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energy, half-harmonic potentials (walls) were added to penalize
exploration of CV values below or above minimum/maximum
values such that the computed free energy profiles are within
approximately 10 kBT from the global minimum. The position of
the walls was chosen by performing unrestrained preliminary
BEMD runs.
N Walls: CV1: minimum 57, maximum 96; CV2: minimum 36,
maximum 63; CV3: minimum 1, maximum 9; CV4,
minimum 1.5, maximum 9.9; CV5, minimum 0.50, maximum
10.50; CV6, minimum 0.40, maximum 9.00; CV7 minimum
1.25, maximum 10.25; CV8 minimum 0.33, maximum 0.97.
With this setup the average exchange probability between
biased replicas and neutral replicas was about 33% for both apo
and holo simulations. The input files used to perform the apo and
holo simulations are available in the supporting information
(Dataset S1). On the basis of observed fluctuations in the values of
the CVs over the duration of the BEMD simulations, the first
20 ns of the simulations was discarded to allow the Gaussian biases
to compensate free energy barriers and enable broad sampling
along each CV. The free energy profiles shown in Figure 2 and
Figure 3 were taken as the negative of the averaged metadynamics
biasing potential over the last 100 ns of each simulations.
Two different techniques were used to compute equilibrium
properties from the BEMD ensembles. In the first approach,
snapshots from all the biased replicas were reweighted using the
method of Marinelli et al. [35] In this technique, the biased
trajectories are first clustered in a N-dimensional CV space made
of hypercubes forming a regular grid. The free energy of each bin
is then estimated by a weighted histogram analysis procedure
(WHAM) based on the number of snapshots and the value of the
converged metadynamics bias potentials assigned to each bin. For
the approach to be reliable, a large number of bins must be
populated by several structurally similar snapshots. Increasing the
dimensionality of the CV space decreases the statistics of each bin,
but improves the structural similarity of snapshots within each bin.
Multiple clustering schemes were tested to balance these two
parameters, using the METAGUI plugin, [77] for the VMD
software. [78] The best protocol identified for this system involved
a 4-dimensional clustering using CV1, CV3, CV4, CV5 with a bin
width of approximately 2si, where si is the Gaussian width of
CVi. These 4 CVs were chosen as they were found to be the least
correlated with each other, thus maximizing structural similarity of
snapshots assigned to each bin. The bin width of 2si is on the
order of the resolution of the metadynamics free energy profiles.
With this setup about 9000 bins contained at least 5 snapshots.
Lower dimensionality clustering produced bins that lumped
together structurally dissimilar states, whereas higher dimension-
ality clustering yielded very few bins populated with more than five
snapshots. Molecular observables were averaged between snap-
shots assigned to the same bin. Ensemble properties were then
obtained by weighting the properties of each bin by its WHAM
derived free energy. In the second technique, ensemble properties
were computed by simple averaging of the properties of each
snapshot recorded in the simulation of the neutral replica.
Two unbiased molecular dynamics simulations of c-Myc402–412
were also performed for comparison with the BEMD simulations
(mdA and mdB). The simulations parameters were identical to the
BEMD simulations, with the exception of the time step that was set
to 5 fs as virtual sites were used, [79] and the simulations duration
was 110 ns. The first 10 ns were discarded to enable relaxation of
the system To evaluate statistical errors for the various computed
properties from all simulations, standard errors were estimated
from properties computed from two independent simulations.
Simulations Analysis
To assess the accuracy of the computed structural ensembles,
the software Camshift was used to predict experimentally
measured backbone H, Ha, Ca and Cb chemical shifts for c-
Myc402–412. [39] Camshift does not predict chemical shifts for N
and C terminal residues so no predictions for Tyr402 and Lys412
could be made. Secondary structure preferences were computed
using several algorithms. DSSP, [40] STRIDE, [41] and PROSS.
[42] The webserver d2D was used to estimate secondary structure
preferences from the measured chemical shifts. [43] For the
BEMD simulations, the probability of contacts between protons in
different peptide residues or the ligand was computed for the apo
and holo ensembles and expressed as a contact matrix. A cutoff of
3 A˚ was used to define a proton-proton contact, which is
intermediate between distances compatible with strong/medium
NOEs. Small variations in this cutoff (60.5A˚) did not affect
significantly the observed trends. RMSD clustering was performed
using the method of Daura et al. to identify structurally distinct
clusters of protein conformations and to estimate their population.
In this approach, the RMSD of atom positions between all pairs of
structures in a trajectory is first determined. For each structure, the
number of structures that have a RMSD below a cutoff value are
counted. The structure with the highest number of neighboring
structures defines a cluster centre. This structure, along with all
neighboring structures, is removed from the trajectory. This
procedure is iterated until no structures are left unassigned. An
advantage of this algorithm over alternative methods such as k-
means or k-medoids is that the number of clusters is automatically
determined, at the cost of a high memory requirement. [44] To
reduce the memory requirements of the algorithm, a subset of the
biased snapshots was used in the clustering analysis, by only
selecting snapshots from bins that were within 6kT from the bin of
lowest free energy. To estimate errors on the cluster populations,
the ensembles from the two apo/holo simulations were combined.
A RMSD cutoff of 3.5 A˚ was used to group structures. For the apo
ensemble the RMSD calculations were performed using the
coordinates of heavy atoms, excluding atoms that can form
symmetry equivalent conformations (e.g. Valine Cc atoms). For
the holo ensemble, a different protocol was used to finely resolve
different binding modes of the ligand. The RMSD calculations
were performed on the protein Ca and Cb atoms and non-
symmetry equivalent ligand heavy atoms. The ligand coordinates
were weighted by a factor of 3 in the RMSD calculations to in
order to cluster together conformations that contained similar
ligand coordinates.
Supporting Information
Figure S1 Secondary structure content of c-Myc402–412.
Residue secondary structure preferences colored according to the
STRIDE code (white: coil, cyan: turn, blue: 310 helix, purple: a-
helix, maroon: bend, yellow: extended). A) and B) BEMD
ensembles from the neutral replicas for simulations apoA and
apoB. C) and D) Unbiased ensembles from MD simulations mdA
and mdB.
(TIF)
Figure S2 Comparison of computed and observed
secondary chemical shifts for apo c-Myc402–412. A)
1Ha
chemical shifts. B) 13Ca chemical shifts. C)
1H backbone amide
chemical shifts. D) 13Cb chemical shifts. Black: experimental data.
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Red: predicted from MD simulation mdA. Blue: predicted from
MD simulation mdB.
(TIF)
Figure S3 Comparison of free energy profiles of c-
Myc402–412 obtained from the neutral replica and the
biased replicas. Black: Neutral replica, Red: Biased replica.
Data generated using BEMD simulation apoA.
(TIF)
Figure S4 Hydrophobicity plot of the sequence of the c-
Myc and Max bHLHZip domains. Black: c-Myc. Red: Max.
Regions with a positive score are considered hydrophobic. The
location of the c-Myc segment corresponding to amino acids 401
to 406 has been highlighted in bold. Plots generated using a Kyte-
Doolittle hydrophobicity scale. [80] To detect relatively short
sequences of hydrophobic and aromatic sites that may interact
favorably with small organic molecules the scale was modified so
that Tyrosine has a hydrophobicity score equal to Phenylalanine
and a window width of 3 was used. Plots produced using the
sequences c-Myc353–437 (84 amino acids) and Max24–102 (78 amino
acids).
(TIF)
Dataset S1 Input files for the apo and holo BEMD
simulations.
(ZIP)
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